Product name: Selank

Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro

Purity: 95% by HPLC

Counter ion: Trifluoacetate

Format: Lyophilized powder

Description: A synthetic derivative of the endogenous peptide tuftsin heptapeptide selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) possesses an anxiolytic and psychostimulant effect, and represents a working element of a new peptide drug having completed the third phase of the clinical testing as a selective anxiolytic. The neurobiochemical spectrum of selank action combines mechanisms which are characteristics of antidepressants and psychostimulants: activation of the brain monoaminergic systems, dopamine synthesis and turnover, and modulation of the tyrosine hydroxylase activity.  Selank is able to regulate ion homeostasis of hippocampal cells and thereby modulate different ion-dependent processes, which include the processes of learning and memory formation.

Usage: For Scientific Research Use Only, Not for Human Use.

Reference:

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):33-40.

Dokl Biol Sci. 2014 Sep;458:267-70.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(7):17-22.

Bull Exp Biol Med. 2014 May;157(1):52-5.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2013 May-Jun;63(3):365-74.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2008 Mar-Apr;58(2):226-37.

Zh Nevrol Psikhiatr Im S S Korsakova. 2008; 108(4):38-48.

Zh Nevrol Psikhiatr Im S S Korsakova. 2008; 108(5):71-5.